Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

ClickSlim vs NowPatient

ClickSlim
Graded #490

Lower grade

vs+15.600000000000001
NowPatient
Graded #222

Higher grade

The verdict

NowPatient takes it — 65.5/100 to 49.9/100.

NowPatient grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNowPatient +3
32
35
Dose & formulationNowPatient +41
52
93
Clinical oversightNowPatient +26
60
86
Labs & monitoringNowPatient +2
52
54
FulfillmentNowPatient +5
65
70
Contract termsNowPatient +6
49
55
ClickSlim · left barNowPatient · right bar

The numbers

MetricClickSlimNowPatient
WeighScore49.9/10065.5/100
GradeCC
Scorecard rank#490#222
SemaglutideNot disclosed$1,349/mo (brand Wegovy)
Tirzepatide$349/mo (compounded)$1,069/mo (brand Mounjaro, promotional rate)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
ClickSlim

Graded #490 · C

Strengths

  • Both the introductory and the ongoing price are published, so the step-up is visible before you buy
  • States plainly that it is not a pharmacy or a drug manufacturer and that medication is dispensed by a licensed third party
  • Text support line published with stated hours
  • LegitScript certification verified against the issued seal, not just the badge

Where it loses points

  • Its own NAD+ product card is labelled CONTAINS TIRZEPATIDE, which contradicts the product it is selling
  • No state list is published; the site says only that services are available in most States
  • Prices are among the highest in the category, at $349 ongoing for tirzepatide
  • Registered at a Sheridan, Wyoming suite address commonly used as a mail-forwarding and registered-agent address
  • Terms set arbitration in San Diego under California law while the company address is in Wyoming
NowPatient

Graded #222 · C

Strengths

  • Free telehealth consultation — you only pay for the medication
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand-name

Where it loses points

  • Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
  • No compounded semaglutide or tirzepatide (usually the cheaper route)
  • State availability determined during intake, not shown upfront
  • Does not offer Foundayo (orforglipron)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard